应交易所要求,美/港股行情延时15分钟展示,下载APP即可免费查看实时行情。
关闭
TRML Tourmaline Bio
停牌 10-27 16:00:00 EDT
47.98
+0.00
0.00%
最高
47.98
最低
47.98
成交量
0.00
今开
47.98
昨收
47.98
日振幅
0.00%
总市值
12.36亿
流通市值
6.29亿
总股本
2,576万
成交额
3,761万
换手率
0.00%
流通股本
1,312万
市净率
--
ROE
--
每股收益
0.00
52周最高
--
52周最低
--
市盈率
--
股息
--
股息收益率
--
ROA
--
分时
五日
日K
周K
月K
数据加载中...
北京优虎网络科技有限公司
资讯
新帖
简况
诺华制药 - 收购完成,普通股(每股面值$0.0001)股份情况
美股速递 · 10-28
诺华制药 - 收购完成,普通股(每股面值$0.0001)股份情况
诺华制药完成对TOURMALINE BIO的收购
新浪财经 · 10-28
诺华制药完成对TOURMALINE BIO的收购
Novartis AG收购要约将于2025年10月27日到期,除非延期
美股速递 · 09-29
Novartis AG收购要约将于2025年10月27日到期,除非延期
Novartis通过子公司启动要约收购 拟以每股48美元现金收购Tourmaline Bio全部流通股
美股速递 · 09-29
Novartis通过子公司启动要约收购 拟以每股48美元现金收购Tourmaline Bio全部流通股
Tourmaline Bio:Piper Sandler将评级从增持下调至中性,目标价从65美元下调至48美元
美股速递 · 09-11
Tourmaline Bio:Piper Sandler将评级从增持下调至中性,目标价从65美元下调至48美元
美股周二早盘诺华制药公司(NVS)股价小幅下跌此前该公司宣布将以14亿美元全现金交易收购Tourmaline Bio。
智通财经 · 09-09
美股周二早盘诺华制药公司(NVS)股价小幅下跌此前该公司宣布将以14亿美元全现金交易收购Tourmaline Bio。
美股异动 | 被诺华约14亿美元收购 Tourmaline Bio(TRML.US)飙升超57%
智通财经 · 09-09
美股异动 | 被诺华约14亿美元收购 Tourmaline Bio(TRML.US)飙升超57%
生物技术公司Tourmaline Bio爆升近60%此前公司宣布与诺华达成收购协议。
智通财经 · 09-09
生物技术公司Tourmaline Bio爆升近60%此前公司宣布与诺华达成收购协议。
Tourmaline Bio:如合并交易终止,Novartis需在特定情况下向公司支付6850万美元终止费
美股速递 · 09-09
Tourmaline Bio:如合并交易终止,Novartis需在特定情况下向公司支付6850万美元终止费
盘前异动丨NEBIUS、WOLF、TRML等股暴涨,36氪、房多多回调
老虎资讯综合 · 09-09
盘前异动丨NEBIUS、WOLF、TRML等股暴涨,36氪、房多多回调
诺华制药(NVS.US)以每股48美元收购Tourmaline Bio(TRML.US) 加码心血管疾病疗法
智通财经 · 09-09
诺华制药(NVS.US)以每股48美元收购Tourmaline Bio(TRML.US) 加码心血管疾病疗法
美股异动丨Tourmaline Bio夜盘拉升涨超17%
格隆汇 · 09-09
美股异动丨Tourmaline Bio夜盘拉升涨超17%
诺华同意以每股48美元现金收购生物制药公司Tourmaline Bio
老虎资讯综合 · 09-09
诺华同意以每股48美元现金收购生物制药公司Tourmaline Bio
诺华将收购Tourmaline Bio以补充心血管产品线。
智通财经 · 09-09
诺华将收购Tourmaline Bio以补充心血管产品线。
Tourmaline Bio在2025年欧洲心脏病学会大会上展示正在进行的二期Tranquility试验数据
美股速递 · 08-31
Tourmaline Bio在2025年欧洲心脏病学会大会上展示正在进行的二期Tranquility试验数据
Tourmaline Bio, Inc.盘中异动 急速下挫5.39%
市场透视 · 08-09
Tourmaline Bio, Inc.盘中异动 急速下挫5.39%
Tourmaline Bio, Inc.盘中异动 临近午盘急速拉升5.33%
市场透视 · 08-05
Tourmaline Bio, Inc.盘中异动 临近午盘急速拉升5.33%
Tourmaline Bio, Inc.盘中异动 临近收盘股价大跌5.01%
市场透视 · 08-01
Tourmaline Bio, Inc.盘中异动 临近收盘股价大跌5.01%
Tourmaline Bio, Inc.盘中异动 早盘股价大涨5.44%报20.85美元
市场透视 · 07-28
Tourmaline Bio, Inc.盘中异动 早盘股价大涨5.44%报20.85美元
Tourmaline Bio, Inc.盘中异动 急速上涨5.01%报18.88美元
市场透视 · 07-15
Tourmaline Bio, Inc.盘中异动 急速上涨5.01%报18.88美元
加载更多
公司概况
公司名称:
Tourmaline Bio
所属市场:
NASDAQ
上市日期:
--
主营业务:
Tourmaline Bio, Inc.在特拉华州注册成立。该公司是一家处于后期阶段的临床生物技术公司,其使命是开发具有变革性的药物,极大地改善患有改变生命的免疫疾病的患者的生活。他们的先导项目TOUR006是一种抗IL-6抗体,它表现出不同的特性,包括对IL-6的高结合亲和力和自然较长的半衰期。迄今为止,TOUR006已在六项临床试验中对400多名自身免疫患者进行了研究。该公司计划开发治疗甲状腺眼病(TED)和动脉粥样硬化性心血管病(ASCVD)的TOUR006,分别作为其主要适应症和次要适应症,其他适应症正在考虑之中。
发行价格:
--
{"stockData":{"symbol":"TRML","market":"US","secType":"STK","nameCN":"Tourmaline Bio","latestPrice":47.98,"timestamp":1761595200000,"preClose":47.98,"halted":3,"volume":0,"delay":0,"floatShares":13117896,"shares":25756021,"eps":-3.435149,"marketStatus":"停牌","change":0,"latestTime":"10-27 16:00:00 EDT","open":47.98,"high":47.98,"low":47.98,"amount":37610716.7874,"amplitude":0,"askPrice":0,"askSize":0,"bidPrice":0,"bidSize":0,"shortable":3,"etf":0,"ttmEps":-3.435149,"tradingStatus":0,"nextMarketStatus":{"tag":"盘前交易","tradingStatus":1,"beginTime":1765184400000},"marketStatusCode":7,"adr":0,"listingDate":1620360000000,"exchange":"NASDAQ","adjPreClose":47.98,"volumeRatio":0},"requestUrl":"/m/hq/s/TRML","defaultTab":"news","newsList":[{"id":"1100720406","title":"诺华制药 - 收购完成,普通股(每股面值$0.0001)股份情况","url":"https://stock-news.laohu8.com/highlight/detail?id=1100720406","media":"美股速递","labels":["corporation","merge"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1100720406?lang=zh_cn&edition=full","pubTime":"2025-10-28 21:57","pubTimestamp":1761659829,"startTime":"0","endTime":"0","summary":"诺华制药 - 收购完成,普通股(每股面值$0.0001)股份情况","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"corporation,merge","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["TRML","BK4539","BK4139"],"gpt_icon":0},{"id":"2579499307","title":"诺华制药完成对TOURMALINE BIO的收购","url":"https://stock-news.laohu8.com/highlight/detail?id=2579499307","media":"新浪财经","labels":["corporation","merge"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2579499307?lang=zh_cn&edition=full","pubTime":"2025-10-28 21:55","pubTimestamp":1761659748,"startTime":"0","endTime":"0","summary":"诺华制药完成对TOURMALINE BIO的收购。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202510282221399746da89&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202510282221399746da89&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation,merge","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["LU1169589451.USD","IE00BJT1NW94.SGD","BK4578","IE00B4R5TH58.HKD","LU0211331839.USD","BK4532","BK4585","BIO","TRML","LU0208291251.USD","IE00BFTCPJ56.SGD","LU1169590202.USD","LU0320765489.SGD","IE00B2B36J28.USD","BK4588","IE00BJJMRZ35.SGD","BK4121","NVS","LU0070302665.USD","BK4539","IE0002141913.USD","IE0009355771.USD","BK4007","BK4139"],"gpt_icon":0},{"id":"1104975180","title":"Novartis AG收购要约将于2025年10月27日到期,除非延期","url":"https://stock-news.laohu8.com/highlight/detail?id=1104975180","media":"美股速递","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1104975180?lang=zh_cn&edition=full","pubTime":"2025-09-29 19:48","pubTimestamp":1759146498,"startTime":"0","endTime":"0","summary":"Novartis AG宣布,其收购要约将于2025年10月27日纽约时间晚上11:59分后一分钟正式到期,除非该要约获得延期。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4139","TRML","BK4539"],"gpt_icon":0},{"id":"1109222319","title":"Novartis通过子公司启动要约收购 拟以每股48美元现金收购Tourmaline Bio全部流通股","url":"https://stock-news.laohu8.com/highlight/detail?id=1109222319","media":"美股速递","labels":["shareholding","merge"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1109222319?lang=zh_cn&edition=full","pubTime":"2025-09-29 19:47","pubTimestamp":1759146436,"startTime":"0","endTime":"0","summary":"Novartis Ag通过其子公司Torino Merger Sub Inc已启动要约收购程序,计划收购Tourmaline Bio全部已发行普通股。根据收购条款,每股面值0.0001美元的普通股将以48美元现金价格进行收购,且不计利息。\n此次要约收购针对Tourmaline Bio的所有流通在外普通股,收购方式为现金交易。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding,merge","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["TRML","BK4539","BK4139"],"gpt_icon":0},{"id":"1172692493","title":"Tourmaline Bio:Piper Sandler将评级从增持下调至中性,目标价从65美元下调至48美元","url":"https://stock-news.laohu8.com/highlight/detail?id=1172692493","media":"美股速递","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1172692493?lang=zh_cn&edition=full","pubTime":"2025-09-11 20:50","pubTimestamp":1757595018,"startTime":"0","endTime":"0","summary":"Tourmaline Bio:Piper Sandler将评级从增持下调至中性,目标价从65美元下调至48美元。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["TRML","BK4139","BK4539"],"gpt_icon":0},{"id":"2566061542","title":"美股周二早盘诺华制药公司(NVS)股价小幅下跌此前该公司宣布将以14亿美元全现金交易收购Tourmaline Bio。","url":"https://stock-news.laohu8.com/highlight/detail?id=2566061542","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2566061542?lang=zh_cn&edition=full","pubTime":"2025-09-09 22:39","pubTimestamp":1757428792,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"43c9b39c5bc682e12986f02d017a3c05","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.zhitongcaijing.com/immediately.html?type=usstock","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"live_zhitongcaijing","symbols":["BK4585","IE00B2B36J28.USD","BK4139","TRML","LU0070302665.USD","IE00B4R5TH58.HKD","BK4532","01477","IE00BJJMRZ35.SGD","LU0211331839.USD","BK4588","BK4578","IE00BFTCPJ56.SGD","IE00BJT1NW94.SGD","NVS","IE0002141913.USD","BK1574","BK4007","BK4539","LU0208291251.USD","BK1191","LU0320765489.SGD","IE0009355771.USD"],"gpt_icon":0},{"id":"2566840615","title":"美股异动 | 被诺华约14亿美元收购 Tourmaline Bio(TRML.US)飙升超57%","url":"https://stock-news.laohu8.com/highlight/detail?id=2566840615","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2566840615?lang=zh_cn&edition=full","pubTime":"2025-09-09 22:11","pubTimestamp":1757427106,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.zhitongcaijing.com/immediately.html?type=usstock","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"live_zhitongcaijing","symbols":["IE00BJT1NW94.SGD","BK4585","TRML","IE00B4R5TH58.HKD","BK4007","BK4139","BK4539","LU0208291251.USD","LU0320765489.SGD","NVS","IE00BJJMRZ35.SGD","BK4532","BK4588","LU0211331839.USD","IE00BFTCPJ56.SGD","IE0009355771.USD","IE0002141913.USD","LU0070302665.USD","BK4578","IE00B2B36J28.USD"],"gpt_icon":0},{"id":"2566618739","title":"生物技术公司Tourmaline Bio爆升近60%此前公司宣布与诺华达成收购协议。","url":"https://stock-news.laohu8.com/highlight/detail?id=2566618739","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2566618739?lang=zh_cn&edition=full","pubTime":"2025-09-09 21:42","pubTimestamp":1757425339,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"43c9b39c5bc682e12986f02d017a3c05","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.zhitongcaijing.com/immediately.html?type=usstock","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"live_zhitongcaijing","symbols":["BK4578","BK4539","LU0211331839.USD","BK4007","IE00BJT1NW94.SGD","BK4588","LU0070302665.USD","IE00BJJMRZ35.SGD","IE0009355771.USD","IE00B2B36J28.USD","LU0208291251.USD","BK4139","IE00B4R5TH58.HKD","TRML","IE00BFTCPJ56.SGD","LU0320765489.SGD","BK4532","IE0002141913.USD","NVS","BK4585"],"gpt_icon":0},{"id":"1139127745","title":"Tourmaline Bio:如合并交易终止,Novartis需在特定情况下向公司支付6850万美元终止费","url":"https://stock-news.laohu8.com/highlight/detail?id=1139127745","media":"美股速递","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1139127745?lang=zh_cn&edition=full","pubTime":"2025-09-09 18:14","pubTimestamp":1757412868,"startTime":"0","endTime":"0","summary":"根据监管文件显示,Tourmaline Bio披露了与Novartis合并协议中的重要条款。文件显示,如果双方的合并交易在特定情况下被终止,Novartis将需要向Tourmaline Bio支付6850万美元的终止费用。\n这一终止费条款为Tourmaline Bio在合并交易可能失败的情况下提供了一定的财务保障,确保公司能够获得相应的补偿。该条款的具体触发条件和执行细节已在相关监管文件中详细说明。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["TRML","BK4539","BK4139"],"gpt_icon":0},{"id":"1174082328","title":"盘前异动丨NEBIUS、WOLF、TRML等股暴涨,36氪、房多多回调","url":"https://stock-news.laohu8.com/highlight/detail?id=1174082328","media":"老虎资讯综合","labels":["movement"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1174082328?lang=zh_cn&edition=full","pubTime":"2025-09-09 16:04","pubTimestamp":1757405068,"startTime":"0","endTime":"0","summary":"美股三大指数期货在盘前时段小幅上涨。","market":"us","thumbnail":"https://community-static.tradeup.com/news/0f5faa99a83c5ba8a15d531d8d292231","type":0,"news_type":0,"thumbnails":["https://community-static.tradeup.com/news/0f5faa99a83c5ba8a15d531d8d292231"],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":true,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"movement","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["TRML","NBIS","WOLF"],"gpt_icon":1},{"id":"2566669108","title":"诺华制药(NVS.US)以每股48美元收购Tourmaline Bio(TRML.US) 加码心血管疾病疗法","url":"https://stock-news.laohu8.com/highlight/detail?id=2566669108","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2566669108?lang=zh_cn&edition=full","pubTime":"2025-09-09 14:45","pubTimestamp":1757400325,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"5fb54e106e0dea5e9f2c2ac0de52d562","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.zhitongcaijing.com/immediately.html?type=usstock","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"live_zhitongcaijing","symbols":["01477","IE00BFTCPJ56.SGD","BK4139","IE00BJT1NW94.SGD","IE00BJJMRZ35.SGD","LU0320765489.SGD","BK1191","BK4585","LU0211331839.USD","BK4532","NVS","BK4007","BK1574","IE0002141913.USD","LU0070302665.USD","IE00B4R5TH58.HKD","IE0009355771.USD","BK4578","BK4588","IE00B2B36J28.USD","BK4539","LU0208291251.USD","TRML"],"gpt_icon":0},{"id":"2566966327","title":"美股异动丨Tourmaline Bio夜盘拉升涨超17%","url":"https://stock-news.laohu8.com/highlight/detail?id=2566966327","media":"格隆汇","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2566966327?lang=zh_cn&edition=full","pubTime":"2025-09-09 13:27","pubTimestamp":1757395626,"startTime":"0","endTime":"0","summary":null,"market":"sg","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.gelonghui.com/rss/live/live.xml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"live_gelonghui","symbols":["LU0320765489.SGD","BK4588","IE0002141913.USD","BK4539","IE00B4R5TH58.HKD","BK4139","BK4578","LU0211331839.USD","LU0208291251.USD","NVS","BK4532","IE00BJT1NW94.SGD","IE00B2B36J28.USD","TRML","IE00BFTCPJ56.SGD","BK4007","IE0009355771.USD","IE00BJJMRZ35.SGD","BK4585","LU0070302665.USD"],"gpt_icon":0},{"id":"1165302115","title":"诺华同意以每股48美元现金收购生物制药公司Tourmaline Bio","url":"https://stock-news.laohu8.com/highlight/detail?id=1165302115","media":"老虎资讯综合","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1165302115?lang=zh_cn&edition=full","pubTime":"2025-09-09 13:12","pubTimestamp":1757394732,"startTime":"0","endTime":"0","summary":"生物制药公司$Tourmaline Bio(TRML)$涨超16%!$诺华(NVS)$同意以每股48美元现金收购该公司>>","market":"us","thumbnail":"https://static.tigerbbs.com/fd680cd945fd32917c8ece66ec685e5f","type":0,"news_type":0,"thumbnails":["https://static.tigerbbs.com/fd680cd945fd32917c8ece66ec685e5f"],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"5fb54e106e0dea5e9f2c2ac0de52d562","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":true,"source_rank":0,"column":"","sentiment":"0","news_top_title":"诺华同意以每股48美元现金收购生物制药公司Tourmaline Bio","news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4007","IE00B2B36J28.USD","IE00BJJMRZ35.SGD","BK4588","IE00B4R5TH58.HKD","BK4139","BK4532","LU0070302665.USD","LU0211331839.USD","BK4585","IE00BJT1NW94.SGD","IE00BFTCPJ56.SGD","LU0208291251.USD","BK4578","TRML","IE0009355771.USD","LU0320765489.SGD","IE0002141913.USD","BK4539","NVS"],"gpt_icon":0},{"id":"2566663660","title":"诺华将收购Tourmaline Bio以补充心血管产品线。","url":"https://stock-news.laohu8.com/highlight/detail?id=2566663660","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2566663660?lang=zh_cn&edition=full","pubTime":"2025-09-09 13:05","pubTimestamp":1757394350,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"5fb54e106e0dea5e9f2c2ac0de52d562","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.zhitongcaijing.com/immediately.html?type=usstock","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"live_zhitongcaijing","symbols":["IE00B2B36J28.USD","BK4585","LU0070302665.USD","BK4578","IE00BJJMRZ35.SGD","BK4532","IE0002141913.USD","BK4588","LU0211331839.USD","IE00BJT1NW94.SGD","IE00BFTCPJ56.SGD","IE00B4R5TH58.HKD","BK4539","BK4139","LU0320765489.SGD","IE0009355771.USD","BK4007","LU0208291251.USD","TRML","NVS"],"gpt_icon":0},{"id":"1141312299","title":"Tourmaline Bio在2025年欧洲心脏病学会大会上展示正在进行的二期Tranquility试验数据","url":"https://stock-news.laohu8.com/highlight/detail?id=1141312299","media":"美股速递","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1141312299?lang=zh_cn&edition=full","pubTime":"2025-08-31 22:24","pubTimestamp":1756650278,"startTime":"0","endTime":"0","summary":"Tourmaline Bio在2025年欧洲心脏病学会大会上展示正在进行的二期Tranquility试验数据","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4539","BK4139","TRML"],"gpt_icon":0},{"id":"2558814579","title":"Tourmaline Bio, Inc.盘中异动 急速下挫5.39%","url":"https://stock-news.laohu8.com/highlight/detail?id=2558814579","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2558814579?lang=zh_cn&edition=full","pubTime":"2025-08-09 01:16","pubTimestamp":1754673387,"startTime":"0","endTime":"0","summary":"北京时间2025年08月09日01时16分,Tourmaline Bio, Inc.股票出现波动,股价快速下跌5.39%。Tourmaline Bio, Inc.股票所在的生物技术行业中,整体跌幅为0.66%。Tourmaline Bio, Inc.公司简介:Tourmaline Bio Inc 是一家后期阶段的临床生物技术公司,其使命是开发变革性药物,显着改善患有改变生活的免疫疾病患者的生活。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025080901162794d826f3&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025080901162794d826f3&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["TRML","BK4139","BK4539"],"gpt_icon":0},{"id":"2557313361","title":"Tourmaline Bio, Inc.盘中异动 临近午盘急速拉升5.33%","url":"https://stock-news.laohu8.com/highlight/detail?id=2557313361","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2557313361?lang=zh_cn&edition=full","pubTime":"2025-08-05 23:48","pubTimestamp":1754408899,"startTime":"0","endTime":"0","summary":"北京时间2025年08月05日23时48分,Tourmaline Bio, Inc.股票出现异动,股价急速拉升5.33%。Tourmaline Bio, Inc.股票所在的生物技术行业中,整体跌幅为3.32%。Tourmaline Bio, Inc.公司简介:Tourmaline Bio Inc 是一家后期阶段的临床生物技术公司,其使命是开发变革性药物,显着改善患有改变生活的免疫疾病患者的生活。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025080523482097359c8d&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025080523482097359c8d&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4539","BK4139","TRML"],"gpt_icon":0},{"id":"2556853484","title":"Tourmaline Bio, Inc.盘中异动 临近收盘股价大跌5.01%","url":"https://stock-news.laohu8.com/highlight/detail?id=2556853484","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2556853484?lang=zh_cn&edition=full","pubTime":"2025-08-01 03:59","pubTimestamp":1753991979,"startTime":"0","endTime":"0","summary":"北京时间2025年08月01日03时59分,Tourmaline Bio, Inc.股票出现异动,股价大幅下挫5.01%。Tourmaline Bio, Inc.股票所在的生物技术行业中,整体涨幅为1.39%。Tourmaline Bio, Inc.公司简介:Tourmaline Bio Inc 是一家后期阶段的临床生物技术公司,其使命是开发变革性药物,显着改善患有改变生活的免疫疾病患者的生活。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025080103593994c705f8&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025080103593994c705f8&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["TRML","BK4539","BK4139"],"gpt_icon":0},{"id":"2554704577","title":"Tourmaline Bio, Inc.盘中异动 早盘股价大涨5.44%报20.85美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2554704577","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2554704577?lang=zh_cn&edition=full","pubTime":"2025-07-28 21:36","pubTimestamp":1753709791,"startTime":"0","endTime":"0","summary":"北京时间2025年07月28日21时36分,Tourmaline Bio, Inc.股票出现异动,股价急速拉升5.44%。截至发稿,该股报20.85美元/股,成交量5105股,换手率0.02%,振幅2.58%。Tourmaline Bio, Inc.股票所在的生物技术行业中,整体涨幅为0.22%。Tourmaline Bio, Inc.公司简介:Tourmaline Bio Inc 是一家后期阶段的临床生物技术公司,其使命是开发变革性药物,显着改善患有改变生活的免疫疾病患者的生活。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250728213631a467db57&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250728213631a467db57&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["TRML","BK4539","BK4139"],"gpt_icon":0},{"id":"2551135366","title":"Tourmaline Bio, Inc.盘中异动 急速上涨5.01%报18.88美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2551135366","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2551135366?lang=zh_cn&edition=full","pubTime":"2025-07-15 03:47","pubTimestamp":1752522479,"startTime":"0","endTime":"0","summary":"北京时间2025年07月15日03时47分,Tourmaline Bio, Inc.股票出现异动,股价快速上涨5.01%。Tourmaline Bio, Inc.股票所在的生物技术行业中,整体涨幅为0.87%。Tourmaline Bio, Inc.公司简介:Tourmaline Bio Inc 是一家后期阶段的临床生物技术公司,其使命是开发变革性药物,显着改善患有改变生活的免疫疾病患者的生活。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250715034800a44a8ce2&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250715034800a44a8ce2&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"2","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","BK4539","TRML"],"gpt_icon":0}],"profile":{"websiteUrl":"http://www.tourmalinebio.com","stockEarnings":[{"period":"1week","weight":0},{"period":"1month","weight":0},{"period":"3month","weight":0.7943},{"period":"6month","weight":1.4899},{"period":"1year","weight":0.9967},{"period":"ytd","weight":1.3659}],"compareEarnings":[{"period":"1week","weight":0.0034},{"period":"1month","weight":0.012},{"period":"3month","weight":0.0594},{"period":"6month","weight":0.1445},{"period":"1year","weight":0.1303},{"period":"ytd","weight":0.17}],"compareStock":{"symbol":"SPY","name":"标普500ETF"},"description":"Tourmaline Bio, Inc.在特拉华州注册成立。该公司是一家处于后期阶段的临床生物技术公司,其使命是开发具有变革性的药物,极大地改善患有改变生命的免疫疾病的患者的生活。他们的先导项目TOUR006是一种抗IL-6抗体,它表现出不同的特性,包括对IL-6的高结合亲和力和自然较长的半衰期。迄今为止,TOUR006已在六项临床试验中对400多名自身免疫患者进行了研究。该公司计划开发治疗甲状腺眼病(TED)和动脉粥样硬化性心血管病(ASCVD)的TOUR006,分别作为其主要适应症和次要适应症,其他适应症正在考虑之中。","yearOnYearQuotes":[{"month":1,"riseRate":0.5,"avgChangeRate":0.028858},{"month":2,"riseRate":0.5,"avgChangeRate":0.012458},{"month":3,"riseRate":0.5,"avgChangeRate":0.03116},{"month":4,"riseRate":0.5,"avgChangeRate":0.018038},{"month":5,"riseRate":0.25,"avgChangeRate":-0.005311},{"month":6,"riseRate":0.2,"avgChangeRate":-0.104469},{"month":7,"riseRate":0.4,"avgChangeRate":0.118755},{"month":8,"riseRate":0.2,"avgChangeRate":-0.076721},{"month":9,"riseRate":0.6,"avgChangeRate":0.30161},{"month":10,"riseRate":0.4,"avgChangeRate":-0.11954},{"month":11,"riseRate":0.5,"avgChangeRate":-0.027091},{"month":12,"riseRate":0.5,"avgChangeRate":0.013371}],"exchange":"NASDAQ","name":"Tourmaline Bio","nameEN":"Tourmaline Bio"},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"deviceId":"web-server-community-laohu8-v3","version":"4.35.9","shortVersion":"4.35.9","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"Tourmaline Bio(TRML)_个股概要_股票价格_最新资讯_行情走势_历史数据","description":"美港股上老虎。老虎社区提供Tourmaline Bio(TRML)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","keywords":"Tourmaline Bio,TRML,Tourmaline Bio股票,Tourmaline Bio股票老虎,Tourmaline Bio股票老虎国际,Tourmaline Bio行情,Tourmaline Bio股票行情,Tourmaline Bio股价,Tourmaline Bio股市,Tourmaline Bio股票价格,Tourmaline Bio股票交易,Tourmaline Bio股票购买,Tourmaline Bio股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"Tourmaline Bio(TRML)_个股概要_股票价格_最新资讯_行情走势_历史数据","og_description":"美港股上老虎。老虎社区提供Tourmaline Bio(TRML)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","og_image":"https://static.tigerbbs.com/a0b84b8debbbce3b4440f7fdd5eed2e7"}}}